Tumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition.

Hepatic metastatic growth is dependent upon stromal factors including the matrisomal proteins that make up the extracellular matrix (ECM). Laminins are ECM glycoproteins with several functions relevant to tumour progression including angiogenesis. We investigated whether metastatic colon cancer cell...

Full description

Bibliographic Details
Main Authors: Gordon-Weeks, A, Lim, SY, Yuzhalin, A, Lucotti, S, Vermeer, JAF, Jones, K, Chen, J, Muschel, RJ
Format: Journal article
Language:English
Published: MDPI 2019
_version_ 1797105071163441152
author Gordon-Weeks, A
Lim, SY
Yuzhalin, A
Lucotti, S
Vermeer, JAF
Jones, K
Chen, J
Muschel, RJ
author_facet Gordon-Weeks, A
Lim, SY
Yuzhalin, A
Lucotti, S
Vermeer, JAF
Jones, K
Chen, J
Muschel, RJ
author_sort Gordon-Weeks, A
collection OXFORD
description Hepatic metastatic growth is dependent upon stromal factors including the matrisomal proteins that make up the extracellular matrix (ECM). Laminins are ECM glycoproteins with several functions relevant to tumour progression including angiogenesis. We investigated whether metastatic colon cancer cells produce the laminins required for vascular basement membrane assembly as a mechanism for the promotion of angiogenesis and liver metastasis growth. qPCR was performed using human-specific primers to laminin chains on RNA from orthotopic human colorectal liver metastases. Laminin α5 (LAMA5) expression was inhibited in colon cancer cells using shRNA. Notch pathway gene expression was determined in endothelia from hepatic metastases. Orthotopic hepatic metastases expressed human laminin chains α5, β1 and γ1 (laminin 511), all of which are required for vascular basement membrane assembly. The expression of Laminin 511 was associated with reduced survival in several independent colorectal cancer cohorts and angiogenesis signatures or vessel density significantly correlated with LAMA5 expression. Colorectal cancer cells in culture made little LAMA5, but its levels were increased by culture in a medium conditioned by tumour-derived CD11b+ myeloid cells through TNFα/NFκB pathway signalling. Down-regulation of LAMA5 in cancer cells impaired liver metastatic growth and resulted in reduced intra-tumoural vessel branching and increased the expression of Notch pathway genes in metastasis-derived endothelia. This data demonstrates a mechanism whereby tumour inflammation induces LAMA5 expression in colorectal cancer cells. LAMA5 is required for the successful growth of hepatic metastases where it promotes branching angiogenesis and modulates Notch signalling.
first_indexed 2024-03-07T06:42:16Z
format Journal article
id oxford-uuid:f9b479fd-4533-407e-97e8-44f453fea595
institution University of Oxford
language English
last_indexed 2024-03-07T06:42:16Z
publishDate 2019
publisher MDPI
record_format dspace
spelling oxford-uuid:f9b479fd-4533-407e-97e8-44f453fea5952022-03-27T12:59:51ZTumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f9b479fd-4533-407e-97e8-44f453fea595EnglishSymplectic Elements at OxfordMDPI2019Gordon-Weeks, ALim, SYYuzhalin, ALucotti, SVermeer, JAFJones, KChen, JMuschel, RJHepatic metastatic growth is dependent upon stromal factors including the matrisomal proteins that make up the extracellular matrix (ECM). Laminins are ECM glycoproteins with several functions relevant to tumour progression including angiogenesis. We investigated whether metastatic colon cancer cells produce the laminins required for vascular basement membrane assembly as a mechanism for the promotion of angiogenesis and liver metastasis growth. qPCR was performed using human-specific primers to laminin chains on RNA from orthotopic human colorectal liver metastases. Laminin α5 (LAMA5) expression was inhibited in colon cancer cells using shRNA. Notch pathway gene expression was determined in endothelia from hepatic metastases. Orthotopic hepatic metastases expressed human laminin chains α5, β1 and γ1 (laminin 511), all of which are required for vascular basement membrane assembly. The expression of Laminin 511 was associated with reduced survival in several independent colorectal cancer cohorts and angiogenesis signatures or vessel density significantly correlated with LAMA5 expression. Colorectal cancer cells in culture made little LAMA5, but its levels were increased by culture in a medium conditioned by tumour-derived CD11b+ myeloid cells through TNFα/NFκB pathway signalling. Down-regulation of LAMA5 in cancer cells impaired liver metastatic growth and resulted in reduced intra-tumoural vessel branching and increased the expression of Notch pathway genes in metastasis-derived endothelia. This data demonstrates a mechanism whereby tumour inflammation induces LAMA5 expression in colorectal cancer cells. LAMA5 is required for the successful growth of hepatic metastases where it promotes branching angiogenesis and modulates Notch signalling.
spellingShingle Gordon-Weeks, A
Lim, SY
Yuzhalin, A
Lucotti, S
Vermeer, JAF
Jones, K
Chen, J
Muschel, RJ
Tumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition.
title Tumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition.
title_full Tumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition.
title_fullStr Tumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition.
title_full_unstemmed Tumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition.
title_short Tumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition.
title_sort tumour derived laminin α5 lama5 promotes colorectal liver metastasis growth branching angiogenesis and notch pathway inhibition
work_keys_str_mv AT gordonweeksa tumourderivedlaminina5lama5promotescolorectallivermetastasisgrowthbranchingangiogenesisandnotchpathwayinhibition
AT limsy tumourderivedlaminina5lama5promotescolorectallivermetastasisgrowthbranchingangiogenesisandnotchpathwayinhibition
AT yuzhalina tumourderivedlaminina5lama5promotescolorectallivermetastasisgrowthbranchingangiogenesisandnotchpathwayinhibition
AT lucottis tumourderivedlaminina5lama5promotescolorectallivermetastasisgrowthbranchingangiogenesisandnotchpathwayinhibition
AT vermeerjaf tumourderivedlaminina5lama5promotescolorectallivermetastasisgrowthbranchingangiogenesisandnotchpathwayinhibition
AT jonesk tumourderivedlaminina5lama5promotescolorectallivermetastasisgrowthbranchingangiogenesisandnotchpathwayinhibition
AT chenj tumourderivedlaminina5lama5promotescolorectallivermetastasisgrowthbranchingangiogenesisandnotchpathwayinhibition
AT muschelrj tumourderivedlaminina5lama5promotescolorectallivermetastasisgrowthbranchingangiogenesisandnotchpathwayinhibition